| Title: |
Treatment Characteristics and Outcomes of Patients With Chronic/Small Lymphocytic Leukemia (CLL) Treated With Venetoclax and Bruton Tyrosine Kinase Inhibitor (BTKi) Combination Therapies |
| Authors: |
Tuncer, Hande H., Ghosh, Nilanjan, Fleury, Isabelle, Leslie, Lori A., Manzoor, Beenish S., Lamanna, Nicole, Eyre, Toby A., Hill, Brian T., Brown, Jennifer R., Sinai, Wendy, Coombs, Catherine C., Ujjani, Chaitra, Roeker, Lindsey E., Emechebe, Nnadozie, Barr, Paul M., Davids, Matthew S., Martinez-Calle, Nicolas, Rhodes, Joanna M., Lansigan, Frederick, Pearson, Laurie, Choi, Yun, Schuster, Stephen J., Skarbnik, Alan P., Fakhri, Bita, Coyle, Michael, Stephens, Deborah M., Thompson, Meghan C., Jensen, Christopher E., Marx, Steven E., Jawaid, Dureshahwar, Schuh, Anna, Pivneva, Irina, Watson, Talissa, Guerin, Annie, Shadman, Mazyar |
| Source: |
In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S183-S183 |
| Database: |
ScienceDirect |
